161 related articles for article (PubMed ID: 17066390)
1. The importance of the active site histidine for the activity of epoxide- or aziridine-based inhibitors of cysteine proteases.
Mladenovic M; Schirmeister T; Thiel S; Thiel W; Engels B
ChemMedChem; 2007 Jan; 2(1):120-8. PubMed ID: 17066390
[TBL] [Abstract][Full Text] [Related]
2. Atomistic insights into the inhibition of cysteine proteases: first QM/MM calculations clarifying the regiospecificity and the inhibition potency of epoxide- and aziridine-based inhibitors.
Mladenovic M; Junold K; Fink RF; Thiel W; Schirmeister T; Engels B
J Phys Chem B; 2008 May; 112(17):5458-69. PubMed ID: 18393547
[TBL] [Abstract][Full Text] [Related]
3. Rational design of improved aziridine-based inhibitors of cysteine proteases.
Buback V; Mladenovic M; Engels B; Schirmeister T
J Phys Chem B; 2009 Apr; 113(15):5282-9. PubMed ID: 19301885
[TBL] [Abstract][Full Text] [Related]
4. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.
Schirmeister T
J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963
[TBL] [Abstract][Full Text] [Related]
5. Theoretical studies about the influence of different ring substituents on the nucleophilic ring opening of three-membered heterocycles and possible implications for the mechanisms of cysteine protease inhibitors.
Helten H; Schirmeister T; Engels B
J Org Chem; 2005 Jan; 70(1):233-7. PubMed ID: 15624927
[TBL] [Abstract][Full Text] [Related]
6. Atomistic insights into the inhibition of cysteine proteases: first QM/MM calculations clarifying the stereoselectivity of epoxide-based inhibitors.
Mladenovic M; Ansorg K; Fink RF; Thiel W; Schirmeister T; Engels B
J Phys Chem B; 2008 Sep; 112(37):11798-808. PubMed ID: 18712902
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cysteine proteases by peptides containing aziridine-2,3-dicarboxylic acid building blocks.
Schirmeister T
Biopolymers; 1999; 51(1):87-97. PubMed ID: 10380356
[TBL] [Abstract][Full Text] [Related]
8. Rapid kinetic studies and structural determination of a cysteine proteinase mutant imply that residue 158 in caricain has a major effect upon the ability of the active site histidine to protonate a dipyridyl probe.
Katerelos NA; Goodenough PW
Biochemistry; 1996 Nov; 35(47):14763-72. PubMed ID: 8942638
[TBL] [Abstract][Full Text] [Related]
9. Rational design of aziridine-containing cysteine protease inhibitors with improved potency: studies on inhibition mechanism.
Vicik R; Helten H; Schirmeister T; Engels B
ChemMedChem; 2006 Sep; 1(9):1021-8. PubMed ID: 16933238
[TBL] [Abstract][Full Text] [Related]
10. Peptidyl epoxides extended in the P' direction as cysteine protease inhibitors: effect on affinity and mechanism of inhibition.
Perlman N; Hazan M; Shokhen M; Albeck A
Bioorg Med Chem; 2008 Oct; 16(19):9032-9. PubMed ID: 18789705
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of reversible inhibitors of IdeS, a bacterial cysteine protease and virulence determinant.
Berggren K; Johansson B; Fex T; Kihlberg J; Björck L; Luthman K
Bioorg Med Chem; 2009 May; 17(9):3463-70. PubMed ID: 19362485
[TBL] [Abstract][Full Text] [Related]
12. Theoretical study on the mechanism of a ring-opening reaction of oxirane by the active-site aspartic dyad of HIV-1 protease.
Kóna J
Org Biomol Chem; 2008 Jan; 6(2):359-65. PubMed ID: 18175006
[TBL] [Abstract][Full Text] [Related]
13. Aza-peptide epoxides: potent and selective inhibitors of Schistosoma mansoni and pig kidney legumains (asparaginyl endopeptidases).
James KE; Götz MG; Caffrey CR; Hansell E; Carter W; Barrett AJ; McKerrow JH; Powers JC
Biol Chem; 2003 Dec; 384(12):1613-8. PubMed ID: 14719804
[TBL] [Abstract][Full Text] [Related]
14. Cysteine protease inhibitors containing small rings.
Schirmeister T; Klockow A
Mini Rev Med Chem; 2003 Sep; 3(6):585-96. PubMed ID: 12871161
[TBL] [Abstract][Full Text] [Related]
15. Cis-Configured aziridines are new pseudo-irreversible dual-mode inhibitors of Candida albicans secreted aspartic protease 2.
Degel B; Staib P; Rohrer S; Scheiber J; Martina E; Büchold C; Baumann K; Morschhäuser J; Schirmeister T
ChemMedChem; 2008 Feb; 3(2):302-15. PubMed ID: 18038380
[TBL] [Abstract][Full Text] [Related]
16. On the origin of the stabilization of the zwitterionic resting state of cysteine proteases: a theoretical study.
Mladenovic M; Fink RF; Thiel W; Schirmeister T; Engels B
J Am Chem Soc; 2008 Jul; 130(27):8696-705. PubMed ID: 18557615
[TBL] [Abstract][Full Text] [Related]
17. Novel aza peptide inhibitors and active-site probes of papain-family cysteine proteases.
Verhelst SH; Witte MD; Arastu-Kapur S; Fonovic M; Bogyo M
Chembiochem; 2006 Jun; 7(6):943-50. PubMed ID: 16607671
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of cysteine proteases by peptidyl epoxides: characterization of the alkylation sites on the enzyme and the inactivator.
Albeck A; Kliper S
Biochem J; 2000 Feb; 346 Pt 1(Pt 1):71-6. PubMed ID: 10657241
[TBL] [Abstract][Full Text] [Related]
19. A quantum mechanical investigation of possible mechanisms for the nucleotidyl transfer reaction catalyzed by DNA polymerase beta.
Bojin MD; Schlick T
J Phys Chem B; 2007 Sep; 111(38):11244-52. PubMed ID: 17764165
[TBL] [Abstract][Full Text] [Related]
20. Dipeptidyl-alpha,beta-epoxyesters as potent irreversible inhibitors of the cysteine proteases cruzain and rhodesain.
González FV; Izquierdo J; Rodríguez S; McKerrow JH; Hansell E
Bioorg Med Chem Lett; 2007 Dec; 17(24):6697-700. PubMed ID: 17977725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
